Alkermes
ALKS
#3093
Rank
ยฃ3.65 B
Marketcap
ยฃ22.14
Share price
0.75%
Change (1 day)
-10.27%
Change (1 year)

Earnings for Alkermes (ALKS)

Earnings in 2025 (TTM): ยฃ0.31 Billion

According to Alkermes's latest financial reports the company's current earnings are ยฃ1.52 Billion. In 2024 the company made an earning of ยฃ0.34 Billion a decrease over its 2023 earnings that were of ยฃ0.42 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alkermes from 1992 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) ยฃ0.31 B-11.34%
2024 ยฃ0.34 B-17.97%
2023 ยฃ0.42 B-468.52%
2022 -ยฃ0.12 Billion449.24%
2021 -ยฃ21.07 Million-68.04%
2020 -ยฃ65.92 Million-52.1%
2019 -ยฃ0.14 Billion64.49%
2018 -ยฃ83.66 Million-15.04%
2017 -ยฃ98.46 Million-34.2%
2016 -ยฃ0.15 Billion-5.34%
2015 -ยฃ0.16 Billion35084.97%
2014 -ยฃ0.45 Million
2012 ยฃ5.56 M-117.81%
2011 -ยฃ31.27 Million-12.69%
2010 -ยฃ35.81 Million94.3%
2009 -ยฃ18.43 Million-117.7%
2008 ยฃ0.10 B622.63%
2007 ยฃ14.4 M
2004 -ยฃ56.99 Million-14.48%
2003 -ยฃ66.64 Million11.88%
2002 -ยฃ59.56 Million39.65%
2001 -ยฃ42.65 Million5.73%
2000 -ยฃ40.34 Million-28.91%
1999 -ยฃ56.74 Million237.28%
1998 -ยฃ16.83 Million100.05%
1997 -ยฃ8.41 Million-37.93%
1996 -ยฃ13.55 Million82.72%
1995 -ยฃ7.42 Million-26.79%
1994 -ยฃ10.13 Million-72.78%
1993 -ยฃ37.21 Million208.07%
1992 -ยฃ12.08 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Acorda Therapeutics
ACOR
-ยฃ0.21 Billion-167.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ6.02 B 1,880.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ24.29 B 7,886.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ8.88 B 2,822.02%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ9.81 B 3,127.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
ยฃ1.32 B 336.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Zogenix
ZGNX
-ยฃ0.16 Billion-152.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ6.82 B 2,143.60%๐Ÿ‡ซ๐Ÿ‡ท France
Novartis
NVS
ยฃ12.31 B 3,947.98%๐Ÿ‡จ๐Ÿ‡ญ Switzerland